Java plum (Syzygium Cumini) leaves as a potential inhibitor of SARS-CoV-2 3- Chymotrypsine-Like Protease (3CLpro) http://www.doi.org/10.26538/tjnpr/v7i8.8
Article Sidebar
Main Article Content
Abstract
The 3-Chymotrypsine-Like Protease (3CLpro) is an enzyme that has a major function in the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) life cycle. It can be utilized s a protein target in search for new medications. Herbal plants are expected to have major contributions to the prevention and treatment of the 2019 Corona Virus Disease (COVID-19), as many herbal plants might have a strong affinity for 3CLpro in the treatment of COVID-19. The purpose of this study is to examine the inhibitory activity, pytochemical components, and antioxidant of extracts from nine herbal plants extracted by the Ultrasound Assisted Extraction
(UAE) method that have the potential to inhibit recombinant SARS-CoV-2 3CLpro using an in vitro method as a result, it can be used to find novel medication candidates for COVID-19 therapy. Determining antioxidant activity using DPPH and ABTS method, total polyphenol and total flavonoid content using Folin Ciocalteu and quercetin method. From nine herbal plants tested, Java Plum leaves (Syzygium cumini) had the most active inhibitory activity with an inhibitory value of 3CLpro (IC50 = 226 μg/ml) with a total polyphenol 413±1.83 mg GAE/g extract and total flavonoid as 12.091±0.037 mg QE/g extract. Measurement of antioxidant activity with the DPPH obtained an IC50 value of 3.751 ± 0.0149 μg/ml, and with an ABTS gives IC50 value 4.43±0.06μg/ml. This suggests that Java Plum leaves could be a potential source of anti-COVID.
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
Pilz S, Ioannidis JPA. Does natural and hybrid immunity obviate the need for frequent vaccine boosters against SARS‐CoV‐2 in the endemic phase? Eur J Clin Invest. 2023;53(2). doi:10.1111/eci.13906
Glaab E, Manoharan GB, Abankwa D. Pharmacophore model for SARS-CoV-2 3CLpro small-molecule inhibitors and in vitro experimental validation of computationally screened inhibitors. J Chem Inf Model. 2021;61(8):4082-4096.
Chen KY, Krischuns T, Varga LO, Souiai E.H, Paisant S, Zettor A, Chiaravalli J, Delpal A, Courtney D, Brien AO, baker SC, Decrloy E, Isel C, Agou F, Jacob Y, Blondel A, Naffakh N. A highly sensitive cell-based luciferase assay for high-throughput automated screening of SARS-CoV-2
nsp5/3CLpro inhibitors. Antiviral Res.2022;201:105272. doi:10.1016/j.antiviral.2022.105272
ul Qamar MT, Alqahtani SM, Alamri MA, Chen LL. Structural basis of SARS-CoV-2 3CLpro and anti-COVID-19 drug discovery from medicinal plants. J Pharm Anal. 2020;10(4):313-319.
Chen YW, Yiu CPB, Wong KY. Prediction of the SARSCoV-2 (2019-nCoV) 3C-like protease (3CLpro) structure: virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates. F1000Res. 2020; 9:129. doi:10.12688/f1000research.22457.2
Lamb YN. Nirmatrelvir Plus Ritonavir: First Approval. 2022; 82:585-591. doi:10.1007/s40265-022-01692-5
Srivastava N, Garg P, Srivastava P, Seth PK. A molecular dynamics simulation study of the ACE2 receptor with screened natural inhibitors to identify novel drug candidate against COVID-19. PeerJ. 2021;9:e11171.
Utomo W. The comparison of k-means and k-medoids algorithms for clustering the spread of the covid-19 outbreak in Indonesia. ILKOM Jurnal Ilmiah. 2021; 13(1):31-35.
Arya R, Das A, Prashar V, Kumar M. Potential inhibitors against papain-like protease of novel coronavirus (COVID-19) from FDA approved drugs. Published online 2020.
Chen YW, Yiu CPB, Wong KY. Prediction of the SARSCoV-2 (2019-nCoV) 3C-like protease (3CLpro) structure: Virtual screening reveals velpatasvir, ledipasvir, and other drug repurposing candidates. F1000Res. 2020;9. doi:10.12688/f1000research.22457.2
Firdayani R, Helianti I. Inhibition of SARS-Cov-2 proteases by medicinal plant bioactive constituents: Molecular docking simulation. In: 2nd International Conference on Tropical Wetland Biodiversity and Conservation, ICWEB 2021; 2022.
Yang F, Jiang X lan, Tariq A, Sadia S, Ahmed Z, Sardans J, Allem M, Ullah R, Bussmann RW. Potential medicinal plants involved in inhibiting 3CLpro activity: A practical alternate approach to combating COVID-19. J Integr Med. Published online 2022.
Guijarro-Real C, Plazas M, Rodríguez-Burruezo A, Prohens J, Fita A. Potential in vitro inhibition of selected plant extracts against SARS-CoV-2 chymotripsin-like protease (3CLPro) activity. Foods. 2021;10(7):1503.
Zhang B, Qi F. Herbal medicines exhibit a high affinity for ACE2 in treating COVID-19. Biosci Trends. Publishedonline 2023:1534-2022.
Robbani S, Elya B, Iswandana R. Alpha-glucosidase and DPP-IV Inhibitory Activities of Ethanol Extract from Caesalpinia sappan, Andrographis paniculata, and Syzygium cumini. Pharmacognosy Journal. 2022;14(3):702-709. doi:10.5530/pj.2022.14.89
Putra I, Ulfah M, Hafizh N, Helianti I. Characterization of recombinant 3CL protease from SarsCov2 produced in E.coli BL21 (DE3) using peptide substrate LGSAVLQ-Rh110. International Journal of Science and Technology. Published online 2023.
Zhu W, Xu M, Chen CZ, Guo H, Shen M, Hu X, Shinn P, Thomas CK, Michael SG, Zheng W. Identification of SARSCoV-2 3CL Protease Inhibitors by a Quantitative HighThroughput Screening. ACS Pharmacol Transl Sci. 2020;3(5):1008-1016. doi:10.1021/acsptsci.0c00108
Fu L, Ye F, Feng Y, Yu F, Wang Q, Wu Y, Zhao C, Sun H, Huang B, Niu P, Song H, Shi Y, Li X, Tan W, Qi J, Gao GF. Both Boceprevir and GC376 efficaciously inhibit SARSCoV-2 by targeting its main protease. Nat Commun. 2020;11(1):4417. doi:10.1038/s41467-020-18233-x
Vuong W, Khan MB, Fischer C, Arutyunova E, Lamer T, Shiekds J, Saffran HA, McKay RT, van Belkum MJ, Joyce MA, Young HS, Tyrrel DL, Vederas JC, Lemiex MJ. Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication. Nat Commun. 2020;11(1):4282.
Ulfah M, Riswoko A, Mulyawati L, et al. Production of Recombinant SARS-CoV-2 3CL-Protease: The Key for the Development of Protease Inhibitors Screening Kit in Search of Potential Herb Cure for COVID-19.; 2022.
Kemenkes RI. Farmakope Herbal Indonesia Edisi II. Jakarta: Kementrian Kesehatan RI. Published online 2017.
Tristantini D, Amalia R. Quercetin concentration and total flavonoid content of anti-atherosclerotic herbs using aluminum chloride colorimetric assay. In: AIP Conference Proceedings. Vol 2193. AIP Publishing LLC; 2019:030012.
Nugraha AP, Rahmadhani D, Puspitaningrum MS, Rizqianti Y, Kharisma V, Ernawati DS. Molecular docking of anthocyanins and ternatin in Clitoria ternatea as coronavirus disease oral manifestation therapy. J Adv Pharm Technol Res. 2021;12(4):362-367. doi:10.4103/japtr.japtr_126_21
Kurniawan E, Krihariyani D. Working goal of Brazilein sappan wood as a candidate for SARS-coV-2 antivirus drug against spike (S) glycoprotein, papain-like proteinase, andmain protease: In silico study. J Adv Pharm Technol Res. 2021;12(3):298.
Sekiou O, Bouziane I, Bouslama Z, Djemel A. In-Silico Identification of Potent Inhibitors of COVID-19 Main Protease (M pro) and Angiotensin Converting Enzyme 2 (ACE2) from Natural Products: Quercetin, Hispidulin, and Cirsimaritin Exhibited Better Potential Inhibition than
Hydroxy-Chloroquine against COVID-19 Main Protease Active Site and ACE2. https://pubchem.ncbi.nlm.nih.gov/
Kumar M, Tomar M, Amarowicz R, Saurabh V, Nair MS, Maheshwari C, Sasi M, Prajapati U, Hasan M, Singh S, Changan S, Prajapat RK, Berwal MK, Satankar V. Guava (Psidium guajava L.) Leaves: Nutritional Composition, Phytochemical Profile, and Health-Promoting Bioactivities.
Published online 2021. doi:10.3390/foods10040752
Hariono M, Hariyono P, Dwiastuti R, Setyani W, Yusuf M, Salin N, Wahab H..Potential SARS-CoV-2 3CLpro inhibitors from chromene, flavonoid and hydroxamic acid compound based on FRET assay, docking and pharmacophore studies. Results Chem. 2021; 3:100195.
Enmozhi SK, Raja K, Sebastine I, Joseph J. Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: an in silico approach. J Biomol Struct Dyn. 2021;39(9):3092-3098.
Aini NS, Kharisma VD, Widyananda MH, Murtadlo AAA, Probojati RT, Turista DDR, Tamam MB, Jakhmola V, Sari DP, Albari MT, Pernamasari D, Ghifari MA, Ghifari MR, Mandeli RS, Muhardi, Oktavia B, Sari TK, Sriwahyuni T, Azhari P, Maahury MF, Ansori ANM, zainul R. In silico
screening of bioactive compounds from Syzygium cumini L. and moringa oleifera L. against SARS-CoV-2 via tetra inhibitors. Pharmacogn J.2022;14(4):267-272.
Mengist HM, Fan X, Jin T. Designing of improved drugs for COVID-19: Crystal structure of SARS-CoV-2 main protease Mpro. Signal Transduct Target Ther. 2020;5(1):67-68
Fu L, Ye F, Feng Y, Wang Q, Wu Y, Zhao C, Sun H, Huang B, Niu P, Song H, Shi Y, Li X, Tan W, Qi J, Gao GF. Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease. Nat Commun. 2020;11(1):4417.
Kuo CJ, Chao TL, Kao HC, Tsai YM, Liu YK, Chingwang LH, Hsieh MC, Chang SY, Liang PH. Kinetic characterization and inhibitor screening for the proteases leading to identification of drugs against SARS-CoV-2. Antimicrob Agents Chemother. 2021;65(4):e02577-20.
Ayyanar M, Subash-Babu P. Syzygium cumini (L.) Skeels: A review of its phytochemical constituents and traditional uses. Asian Pac J Trop Biomed. 2012;2(3):240-246.
Kharat SN, Ansari N, Mendhulkar VD. HPTLC screening for Flavonoids content in leaf extracts of Syzygium cumini (Linn.) and its Antimicrobial activity. Res J Pharm Technol. 2020;13(6):2720-2726.
Chhikara N, Kaur R, Jaglan S, Sharma P, Gat Y, Panghal A. Food & Function REVIEW Bioactive compounds and pharmacological and food applications of Syzygium cuminia review. Published online 2018. doi:10.1039/c8fo00654g
Jagetia GC. Phytochemical Composition and Pleotropic Pharmacological Properties of Jamun, Syzygium Cumini Skeels. J Explor Res Pharmacol. 2017;2(2):54-66. doi:10.14218/jerp.2016.00038
Silva S do N, Abreu IC, Silva GFC, Ribeiro RM, Lopes AdS, Cartagenes MS, Freire SMdF, Borges ACR, Borges MOdR. The toxicity evaluation of Syzygium cumini leaves in rodents. Revista Brasileira de Farmacognosia. 2012; 22:102-108.
Soorya C, Balamurugan S, Ramya S, Neethirajan K, Kandeepan C, Jayakumararaj R. Physicochemical, ADMET and Druggable properties of Myricetin: A Key Flavonoid in Syzygium cumini that regulates metabolic inflammations. Journal of Drug Delivery and Therapeutics. 2021; 11(4):66-73.
Chagas VT, Coelho RMR de S, Gaspar RS, Silva SM da, Mastrogiovanni M, Mendonca Cde J, Ribeiro MN de S, Paes AM de A, Troztchansky A. Protective effects of a polyphenol-rich extract from Syzygium cumini (L.) skeels leaf on oxidative stress-induced diabetic rats. Oxid Med Cell
Longev. 2018; 2018.
Marie-Pierrette NP. COVID-19 infection and oxidative stress: an under-explored approach for prevention and treatment? Pan Afr Med J. 2020;35(Suppl 2).
Chernyak B V, Popova EN, Prikhodko AS, Grebenchikov OA, Zinovkina LA, Zinovkin RA. COVID-19 and oxidative stress. Biochemistry (Moscow). 2020; 85:1543-1553.